Concepedia

Gajalakshmi Singuru

GS

3

Publications

53

Citations

3

H-Index

2022

Active since

Affiliations

Academy of Scientific and Innovative Research(Current)

Indian Institute of Chemical Technology

Sun Pharma Advanced Research (India)

Gajalakshmi Singuru is an author at Academy of Scientific and Innovative Research specializing in atherosclerosis, metabolic syndrome, and oxidative stress.

Top concepts

Publications per year

2022–2024

3

Publications

3

Therapeutic efficacies of mitochondria-targeted esculetin and metformin in the improvement of age-associated atherosclerosis via regulating AMPK activation

Sriravali Pulipaka, Gajalakshmi Singuru, Sashikanta Sahoo et al. · GeroScience · 2023 · 20 citations · Full text

, , +13

<scp>DOT1L</scp> regulates <scp>MTDH</scp> ‐mediated angiogenesis in triple‐negative breast cancer: intermediacy of <scp>NF‐κB‐HIF1α</scp> axis

Praveen Neeli, Sashikanta Sahoo, Santosh Karnewar et al. · FEBS Journal · 2022 · 19 citations

Mitochondria-targeted esculetin and metformin delay endothelial senescence by promoting fatty acid β-oxidation: Relevance in age-associated atherosclerosis

Sriravali Pulipaka, Hridya Chempon, Gajalakshmi Singuru et al. · Mechanisms of Ageing and Development · 2024 · 14 citations

Rows per page

1–3 of 3